0001437749-24-022356.txt : 20240709 0001437749-24-022356.hdr.sgml : 20240709 20240709091254 ACCESSION NUMBER: 0001437749-24-022356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240703 FILED AS OF DATE: 20240709 DATE AS OF CHANGE: 20240709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danahy Kevin Patrick CENTRAL INDEX KEY: 0001913245 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 241106448 MAIL ADDRESS: STREET 1: 50 TEABERRY LANE CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PULSE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Pulse Biosciences, Inc. DATE OF NAME CHANGE: 20151210 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 rdgdoc.xml FORM 4 X0508 4 2024-07-03 0001625101 PULSE BIOSCIENCES, INC. PLSE 0001913245 Danahy Kevin Patrick C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 1 Chief Commercial Officer 0 Common Stock 2024-07-03 4 X 0 650 A 36537 D Warrant (right to buy) 11 2024-07-03 4 P 0 325 A 2024-07-03 2029-07-03 Common Stock 325 325 D Warrant (right to buy) 11 2024-07-03 4 P 0 325 A 2024-07-03 2029-07-03 Common Stock 325 325 D The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2024-07-09